A Rare Side Effect due to TNF-Alpha Blocking Agent: Acute Pleuropericarditis with Adalimumab
Tumor necrosis factor-alpha antagonism is an important treatment strategy in patients with rheumatoid arthritis, psoriatic arthritis, vasculitis, and 4 Piece King Bed ankylosing spondylitis.Adalimumab is one of the well-known tumor necrosis factor-alpha blocking agents.There are several side effects reported in patients with adalimumab therapy.Card